110 related articles for article (PubMed ID: 7624904)
21. Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.
Mohrmann M; Ansorge S; Schönfeld B; Brandis M
Pediatr Nephrol; 1994 Aug; 8(4):458-65. PubMed ID: 7524598
[TBL] [Abstract][Full Text] [Related]
22. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
Habs MR; Schmähl D
Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
Ormstad K; Orrenius S; Låstbom T; Uehara N; Pohl J; Stekar J; Brock N
Cancer Res; 1983 Jan; 43(1):333-8. PubMed ID: 6401168
[TBL] [Abstract][Full Text] [Related]
24. Reaction kinetics of cisplatin and its monoaquated species with the modulating agents (di)mesna and thiosulphate.
Leeuwenkamp OR; Neijt JP; van der Vijgh WJ; Pinedo HM
Eur J Cancer; 1991; 27(10):1243-7. PubMed ID: 1835593
[TBL] [Abstract][Full Text] [Related]
25. Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection.
Głowacki R; Wójcik K; Bald E
J Chromatogr A; 2001 Apr; 914(1-2):29-35. PubMed ID: 11358223
[TBL] [Abstract][Full Text] [Related]
26. Rapid liquid chromatographic analysis of mitoxantrone in plasma with C18 sample purification.
el-Yazigi A; Yusuf A
J Pharm Biomed Anal; 1989; 7(7):877-82. PubMed ID: 2562289
[TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of sodium 2-mercaptoethanesulfonate (MESNA) and its metabolite, disulfide form (DIMESNA), in volunteers after oral dosing: a comparison between MESNA and ARGIMESNA.
Pea F; Mazzo M; Miglioli PA; Casiglia E; Pessina A; Moretti V
Pharmacol Res; 1992; 25 Suppl 1():85-6. PubMed ID: 1508821
[No Abstract] [Full Text] [Related]
28. Oral bioavailability of mesna tablets.
Stofer-Vogel B; Cerny T; Borner M; Lauterburg BH
Cancer Chemother Pharmacol; 1993; 32(1):78-81. PubMed ID: 8462128
[TBL] [Abstract][Full Text] [Related]
29. Determination of acrolein in urine by liquid chromatography and fluorescence detection of its quinoline derivative.
al-Rawithi S; el-Yazigi A; Nicholls PJ
Pharm Res; 1993 Nov; 10(11):1587-90. PubMed ID: 8290470
[TBL] [Abstract][Full Text] [Related]
30. In vitro carboplatin-mesna interaction in aqueous solution, human plasma and urine.
Obrocea MM; Nassim MA; Molepo MJ; Shirazi FH; Gallant G; Dulude H; Vincent MD; Stewart DJ; Goel R
Oncol Rep; 1998; 5(6):1493-8. PubMed ID: 9769394
[TBL] [Abstract][Full Text] [Related]
31. Direct, simultaneous measurement of chloramphenicol and its monosuccinate ester in micro-samples of plasma by radial-compression liquid chromatography.
el-Yazigi A; Yusuf A; Al-Humaidan A
Clin Chem; 1987 Oct; 33(10):1814-6. PubMed ID: 3665035
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous determination of BNP7787 and its metabolite mesna in plasma and tissue by micro-HPLC with a dual electrochemical detector.
Verschraagen M; Zwiers TH; Torun E; Donker MG; Reinhoud NJ; Van der Vijgh WJ
J Pharm Sci; 2003 May; 92(5):1040-50. PubMed ID: 12712424
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of BNP7787 and its metabolite mesna in plasma and ascites: a case report.
Verschraagen M; Boven E; Zegers I; Hausheer FH; Van der Vijgh WJ
Cancer Chemother Pharmacol; 2003 Jun; 51(6):525-9. PubMed ID: 12750838
[TBL] [Abstract][Full Text] [Related]
34. Expedient liquid chromatographic assay for paclitaxel in plasma after its administration to cancer patients.
el-Yazigi A; Yusuf A
Ther Drug Monit; 1995 Oct; 17(5):511-5. PubMed ID: 8585115
[TBL] [Abstract][Full Text] [Related]
35. Vibrational spectroscopic studies of mesna and dimesna.
Li YS; Wang Y; Church JS; Garzena F; Zhang Z; An D
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Jun; 59(8):1791-8. PubMed ID: 12736065
[TBL] [Abstract][Full Text] [Related]
36. Improved assay for etoposide in plasma by radial-compression liquid chromatography with electrochemical detection.
el-Yazigi A; Martin CR
Clin Chem; 1987 Jun; 33(6):803-5. PubMed ID: 3594819
[TBL] [Abstract][Full Text] [Related]
37. Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma.
el-Yazigi A; Raines DA
Ther Drug Monit; 1993 Aug; 15(4):305-9. PubMed ID: 8236366
[TBL] [Abstract][Full Text] [Related]
38. Urine mesna excretion after intravenous and oral dosing in ifosfamide-treated children.
Goren MP; Epelman S; Bush DA
Cancer Chemother Pharmacol; 2004 Sep; 54(3):237-40. PubMed ID: 15184993
[TBL] [Abstract][Full Text] [Related]
39. Direct liquid chromatographic micro-measurement of tamoxifen in plasma of cancer patients.
El-Yazigi A; Legayada E
J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):457-62. PubMed ID: 9174284
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites.
Verschraagen M; Boven E; Ruijter R; van der Born K; Berkhof J; Hausheer FH; van der Vijgh WJ
Clin Pharmacol Ther; 2003 Aug; 74(2):157-69. PubMed ID: 12891226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
